Pressure BioSciences (OTCQB: PBIO) (“PBI”) today unveiled
its intention to further commit substantial financial and operational support
to fast-track the development of its Ultra Shear Technology (“UST”) platform,
effective immediately. The company plans to pursue commercialization of its
technology platform into major new markets. “We have committed approximately
2,000 sq. ft. of recently acquired space to our Ultra Shear Technology platform
development and nanoemulsions commercialization program. We view this as an
extraordinary opportunity that offers a range of major new market segments for
PBI. We have instructed our Engineering and R&D personnel to finalize the
development of our first-generation UST instrument and to make the generation
of proof-of-principle nanoemulsion data for multiple product areas their top
priority. We have also reallocated significant time and resources from several
staff members to the UST platform development program,” Pressure BioSciences
President and CEO Richard T. Schumacher stated in the news release. “Finally,
we are rapidly accelerating discussions with multiple U.S., Canadian, and other
companies, academic organizations, and government agencies that have expressed
a strong desire to collaborate with PBI and acquire access to our proprietary
UST process. We are on course to establish collaborative development projects
with multiple companies and research groups addressing different product and
market opportunities. These programs should lead to revenue-generating products
in the near future. We believe there are many industries that can benefit from
UST-produced nanoemulsions and that this can be an area of rapid and sizeable
growth for PBI moving forward.”
To view the full press release, visit http://ibn.fm/vTMNg
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. Our products are based on the unique
properties of both constant (i.e., static) and alternating (i.e., pressure
cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling
technology platform that uses alternating cycles of hydrostatic pressure
between ambient and ultra-high levels to safely and reproducibly control
bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our
primary focus is in the development of PCT-based products for biomarker and
target discovery, drug design and development, biotherapeutics characterization
and quality control, soil & plant biology, forensics, and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of our pressure-based technologies in the following areas: (1) the use of
our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into
the biologics contract research services sector, and (2) the use of our
recently-patented, scalable, high-efficiency, pressure-based Ultra Shear
Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise
immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality,
homogenized, extended shelf-life or room temperature stable low-acid liquid
foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment